Total Funding
74
69
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
215522
USSF manufactures sterile injectable pharmaceuticals used by healthcare providers or in new drug or vaccine clinical trials.
Garry Morefield: Co-Founder, COOPast Role: Sanofi Pasteur, Deputy Director
Kyle Flanigan: Co-Founder, CEO
About the Company
US Specialty Formulations manufactures sterile injectable pharmaceuticals used by healthcare providers or in new drug or vaccine clinical trials. Millions of Americans require specialized and custom-manufactured drugs, and the current infrastructure is insufficient to support their therapies. These specially prepared drugs are U.S. Food & Drug
Administration (FDA)-approved medications and are provided globally.
